Brief: Nanexa's PharmaShell To Be Granted Patent In Europe
July 7 (Reuters) - Nanexa AB NANEXA.ST :
* EPO COMMUNICATES INTENTION TO GRANT NANEXA’S PHARMASHELL®
PATENT
IN EUROPE
* FOLLOWING COMPLETION OF SOME INTERNAL CHECKS AND NECESSARY
FORMAL REQUIREMENTS, A PATENT WILL GRANT, ALL BEING WELL, WITHIN
NEXT FEW MONTHS
Source text for Eikon: ID:nMFN9RmL3V
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Nanexa AB
See all newsNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Brief: Nanexa And Novo Enter Global License, Collaboration Deal
Brief: Forge Nano And Nanexa To Develop Gmp-Compatible Ald Manufacturing Equipment
Brief: Nanexa Q2 Revenue Amounted To SEK 1.7 Million
Sweden's Nanexa Q1 revenue falls, loss widens